Actinium Pharmaceuticals Inc (ATNM)
8.96
+0.21
(+2.40%)
USD |
NYAM |
May 03, 16:00
8.915
-0.04
(-0.50%)
After-Hours: 20:00
Actinium Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.081M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | 0.045M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.045M |
| March 31, 2022 | 0.94M |
| December 31, 2021 | 0.023M |
| September 30, 2021 | 0.233M |
| June 30, 2021 | 0.266M |
| March 31, 2021 | 0.622M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.023M
Minimum
Dec 2021
0.94M
Maximum
Mar 2022
0.2819M
Average
0.157M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Eli Lilly and Co | 8.768B |
| Cellectar Biosciences Inc | -- |
| Outlook Therapeutics Inc | -- |
| Bristol-Myers Squibb Co | 11.86B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.67M |
| Total Expenses (Quarterly) | 9.597M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 182.80M |
| Earnings Yield | -19.08% |
| Normalized Earnings Yield | -20.42 |